Diphencyclopropenone (DPCP) for alopecia areata: a UK survey.

Karanovic, S, Harries, M and Kaur, M R (2018) Diphencyclopropenone (DPCP) for alopecia areata: a UK survey. The British journal of dermatology. ISSN 1365-2133. This article is available to all HEFT staff and students via ASK Discovery tool http://tinyurl.com/z795c8c by using their HEFT Athens login IDs

Full text not available from this repository.

Abstract

Alopecia areata (AA) is a T-cell mediated autoimmune hair loss condition with an estimated lifetime risk of 1.7%. It is characterized clinically by sudden-onset non-inflammatory hair loss that may occur at any site. The disease course is unpredictable with many patients experiencing spontaneous re-growth along with episodes of further loss. Unfortunately, around a fifth of patients presenting with patchy alopecia will progress to complete scalp (alopecia totalis (AT)) or scalp & body (alopecia universalis (AU)) hair loss from which spontaneous regrowth is rare (<10%). The adverse psychological consequences of AA include high rates of anxiety and depression. This article is protected by copyright. All rights reserved.

Item Type:	Article
Additional Information:	This article is available to all HEFT staff and students via ASK Discovery tool http://tinyurl.com/z795c8c by using their HEFT Athens login IDs
Subjects:	WR Skin. Dermatology
Divisions:	Ambulatory Care > Dermatology
Related URLs:	https://www.ncbi.nlm.nih.gov/pubmed/?ter...
Depositing User:	Mrs Yolande Brookes
Date Deposited:	07 Mar 2018 12:03
Last Modified:	07 Mar 2018 12:15
URI:	http://www.repository.uhblibrary.co.uk/id/eprint/1613

Actions (login required)

View Item